Clinical trial
A Phase 2, Randomized, Double-blind, Placebo-controlled Proof-of-Concept Study to Evaluate the Efficacy and Safety of Estetrol in Postmenopausal Subjects With Female Sexual Arousal Disorder
NCT06308614 is registered in ClinicalTrials.gov with Estetra as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Double-blind, Placebo-controlled Proof-of-Concept Study to Evaluate the Efficacy and Safety of Estetrol in Postmenopausal Subjects With Female Sexual Arousal Disorder
- Lead sponsor
- Estetra
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 29, 2024
- Completion date
- April 21, 2025
- Enrollment
- 82 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.